GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $84,796,000 | +265.4% | 1,948,000 | +265.7% | 0.46% | +309.8% |
| Q1 2022 | $23,204,000 | +124.8% | 532,700 | +127.6% | 0.11% | +124.0% |
| Q4 2021 | $10,324,000 | -6.5% | 234,100 | -19.0% | 0.05% | -9.1% |
| Q3 2021 | $11,039,000 | -53.3% | 288,900 | -51.3% | 0.06% | -53.4% |
| Q2 2021 | $23,645,000 | +174.2% | 593,800 | +145.8% | 0.12% | +151.1% |
| Q1 2021 | $8,623,000 | +499.2% | 241,600 | +517.9% | 0.05% | +422.2% |
| Q4 2020 | $1,439,000 | +1.4% | 39,100 | +3.7% | 0.01% | -10.0% |
| Q3 2020 | $1,419,000 | -71.9% | 37,700 | -69.5% | 0.01% | -73.0% |
| Q2 2020 | $5,050,000 | -71.1% | 123,800 | -73.1% | 0.04% | -74.5% |
| Q1 2020 | $17,445,000 | +88.9% | 460,400 | +134.3% | 0.14% | +133.9% |
| Q4 2019 | $9,234,000 | -72.0% | 196,500 | -74.6% | 0.06% | -72.9% |
| Q3 2019 | $32,993,000 | -60.8% | 773,032 | -63.2% | 0.23% | -61.3% |
| Q2 2019 | $84,179,000 | -18.0% | 2,103,432 | -14.4% | 0.59% | -19.8% |
| Q1 2019 | $102,684,000 | +7.4% | 2,457,132 | -1.8% | 0.74% | -3.4% |
| Q4 2018 | $95,652,000 | -2.1% | 2,503,332 | +2.9% | 0.76% | +15.4% |
| Q3 2018 | $97,719,000 | +42.0% | 2,432,632 | +42.5% | 0.66% | +35.4% |
| Q2 2018 | $68,809,000 | +16.6% | 1,707,000 | +13.0% | 0.49% | +35.5% |
| Q1 2018 | $59,023,000 | +56.3% | 1,510,700 | +41.9% | 0.36% | +61.9% |
| Q4 2017 | $37,765,000 | +12.4% | 1,064,700 | +28.6% | 0.22% | +13.2% |
| Q3 2017 | $33,613,000 | +155.7% | 827,900 | +171.6% | 0.20% | +169.9% |
| Q2 2017 | $13,143,000 | -48.9% | 304,800 | -50.1% | 0.07% | -49.7% |
| Q1 2017 | $25,734,000 | -63.3% | 610,400 | -66.5% | 0.14% | -61.6% |
| Q4 2016 | $70,095,000 | +4.0% | 1,820,174 | +16.4% | 0.38% | +18.9% |
| Q3 2016 | $67,427,000 | +904.6% | 1,563,336 | +909.4% | 0.32% | +1035.7% |
| Q2 2016 | $6,712,000 | +107.2% | 154,880 | +93.8% | 0.03% | +133.3% |
| Q1 2016 | $3,240,000 | – | 79,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Black Creek Investment Management Inc. | 7,951,626 | $318,224,000 | 10.49% |
| Healthcare Value Capital, LLC | 120,000 | $4,802,000 | 9.01% |
| KAHN BROTHERS GROUP INC | 1,605,014 | $64,232,661,000 | 8.03% |
| Eversept Partners, LP | 693,685 | $28,091,890 | 7.87% |
| EQUITY INVESTMENT CORP | 2,673,764 | $107,004,000 | 3.74% |
| Sio Capital Management, LLC | 379,500 | $15,188,000 | 3.66% |
| Martin Capital Partners, LLC | 115,448 | $4,620,000 | 3.27% |
| Circle Road Advisors LP | 53,028 | $2,122,000 | 3.10% |
| Keystone Financial Planning, Inc. | 156,968 | $6,282,000 | 3.07% |
| CAMG Solamere Management, LLC | 160,294 | $6,415,000 | 2.94% |